Exogene is a biotechnology startup accelerating the discovery of T-cell-receptor(TCR)-based cell therapies for otherwise untreatable solid tumors. They are building a machine learning platform to comprehensively screen TCRs from tumor-infiltrating lymphocytes (TILs) derived from cancer patients to rapidly find new cancer targets and target-specific TCRs for therapeutic application. Using novel wet-lab TCR screening technologies (yeast display combined with mammalian display), Exogene is able to generate data for their machine learning platform in-house by screening billions of TCR-target interactions.
Location: United Kingdom, England, London
Employees: 1-10
Investors 3
| Date | Name | Website |
| 12.06.2021 | Creative D... | creativede... |
| - | Entreprene... | joinef.com |
| - | Unruly Cap... | unrulycap.... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 04.11.2021 | 10 new data-driven health companies selected for KQ Labs acc... | 10 innovative start-up companies working at the interface of biomedical and data science are to rece... | lifearc.or... |